79 related articles for article (PubMed ID: 27346399)
21. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
[TBL] [Abstract][Full Text] [Related]
22. Activity of taspine isolated from Radix et Rhizoma Leonticis against estrogen-receptor-positive breast cancer.
Zhan Y; Zhang Y; Chen Y; Wang N; Zheng L; He L
Fitoterapia; 2011 Sep; 82(6):896-902. PubMed ID: 21605638
[TBL] [Abstract][Full Text] [Related]
23. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.
Li M; Zhao D; Ma G; Zhang B; Fu X; Zhu Z; Fu L; Sun X; Dong JT
Biochem Biophys Res Commun; 2013 Jan; 430(1):358-63. PubMed ID: 23159610
[TBL] [Abstract][Full Text] [Related]
25. Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells.
Wang Y; Jin T; Dai X; Xu J
Biosci Trends; 2016 Feb; 10(1):67-73. PubMed ID: 26902787
[TBL] [Abstract][Full Text] [Related]
26. Novel alternatively spliced variant with a deletion of 52 BP in exon 6 of the progesterone receptor gene is observed frequently in breast cancer tissues.
Hisatomi H; Kohno N; Wakita K; Nagao K; Hirata H; Hikiji K; Harada S
Int J Cancer; 2003 Jun; 105(2):182-5. PubMed ID: 12673676
[TBL] [Abstract][Full Text] [Related]
27. Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels.
Ree AH; Landmark BF; Eskild W; Levy FO; Lahooti H; Jahnsen T; Aakvaag A; Hansson V
Endocrinology; 1989 May; 124(5):2577-83. PubMed ID: 2651098
[TBL] [Abstract][Full Text] [Related]
28. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
Gupta A; Mehta R; Alimirah F; Peng X; Murillo G; Wiehle R; Mehta RG
J Steroid Biochem Mol Biol; 2013 Jan; 133():30-42. PubMed ID: 22939887
[TBL] [Abstract][Full Text] [Related]
30. Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines.
Vienonen A; Syvälä H; Miettinen S; Tuohimaa P; Ylikomi T
J Steroid Biochem Mol Biol; 2002 Mar; 80(3):307-13. PubMed ID: 11948015
[TBL] [Abstract][Full Text] [Related]
31. Integrative genomic analyses of the RNA-binding protein, RNPC1, and its potential role in cancer prediction.
Ding Z; Yang HW; Xia TS; Wang B; Ding Q
Int J Mol Med; 2015 Aug; 36(2):473-84. PubMed ID: 26046131
[TBL] [Abstract][Full Text] [Related]
32. Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer.
Walter KR; Goodman ML; Singhal H; Hall JA; Li T; Holloran SM; Trinca GM; Gibson KA; Jin VX; Greene GL; Hagan CR
Mol Cancer Res; 2017 Oct; 15(10):1331-1340. PubMed ID: 28684637
[TBL] [Abstract][Full Text] [Related]
33. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
[TBL] [Abstract][Full Text] [Related]
34. Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells.
Wei LL; Krett NL; Francis MD; Gordon DF; Wood WM; O'Malley BW; Horwitz KB
Mol Endocrinol; 1988 Jan; 2(1):62-72. PubMed ID: 3398843
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle.
Yang M; Gao H; Chen P; Jia J; Wu S
Oncol Rep; 2013 Jul; 30(1):171-8. PubMed ID: 23624618
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
37. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
Jacobsen BM; Schittone SA; Richer JK; Horwitz KB
Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544
[TBL] [Abstract][Full Text] [Related]
38. hCG activates Epac-Erk1/2 signaling regulating Progesterone Receptor expression and function in human endometrial stromal cells.
Tapia-Pizarro A; Archiles S; Argandoña F; Valencia C; Zavaleta K; Cecilia Johnson M; González-Ramos R; Devoto L
Mol Hum Reprod; 2017 Jun; 23(6):393-405. PubMed ID: 28333280
[TBL] [Abstract][Full Text] [Related]
39. miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells.
Godbole M; Chandrani P; Gardi N; Dhamne H; Patel K; Yadav N; Gupta S; Badwe R; Dutt A
Cancer Biol Ther; 2017 Oct; 18(10):801-805. PubMed ID: 28876975
[TBL] [Abstract][Full Text] [Related]
40. Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas.
Zhang J; Cho SJ; Shu L; Yan W; Guerrero T; Kent M; Skorupski K; Chen H; Chen X
Genes Dev; 2011 Jul; 25(14):1528-43. PubMed ID: 21764855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
